About Alivus Life Sciences Ltd
Alivus Life Sciences is primarily engaged in the development, manufacture, and marketing of active pharmaceutical ingredients.
Founded
2011
CEO
HIREN KARSANBHAI PATEL
Employees
3,950
HQ
Solapur, Maharashtra
Finished Products
1Sale of Products
₹7,028.80Cr2Other Operating Income
₹146.08Cr3Scrap Sale
₹31.47Cr4.Export Incentive
₹14.99Cr5Production Linked Incentive
₹0.59CrRaw Materials
1COST OF MATERIALS CONSUMED
₹3,059.57CrAbout Alivus Life Sciences Ltd
Alivus Life Sciences is primarily engaged in the development, manufacture, and marketing of active pharmaceutical ingredients.
Founded:2011
CEO:HIREN KARSANBHAI PATEL
Employees:3,950
HQ:Solapur, Maharashtra
Finished Products
1Sale of Products
₹7,028.80Cr2Other Operating Income
₹146.08Cr3Scrap Sale
₹31.47Cr4.Export Incentive
₹14.99Cr5Production Linked Incentive
₹0.59CrRaw Materials
1COST OF MATERIALS CONSUMED
₹3,059.57CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,494
52W Low
₹819
Volume561.53K
Avg VolumeN/A
Beta0.60
Dividend Yield0.35%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
29.39x
Valuation
P/B Ratio
5.32x
Valuation
EPS
₹49.12
Valuation
Dividend Yield
0.35%
Valuation
ROE
16.94%
Profitability
ROCE
22.33%
Profitability
Revenue by Segment
Contribution & growth by business line
APIRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
48.3%
International
51.7%
Outside India51.7%
Within India48.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.